Trulay Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 16.26%
- Profit Growth -84.78%
- Ebitda -202.17%
- Net Worth 16.24%
- Total Assets 21.11%
About Trulay Pharmaceuticals
Trulay Pharmaceuticals Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 September 2015 (Nine years and five months 16 days old ). Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nisha Vithlani, Rachana Joshi, and Dharmeshbhai Vara serve as directors at the Company.
Company Details
-
Location
Rajkot, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2015PTC084372
-
Company No.
084372
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Sep 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Trulay Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rachana Joshi
|
Director | 28-Dec-2018 | Current |
|
Nisha Vithlani
|
Director | 01-Sep-2020 | Current |
|
Dharmeshbhai Vara
|
Director | 01-Sep-2015 | Current |
Financial Performance of Trulay Pharmaceuticals.
Trulay Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.26% increase. The company also saw a substantial fall in profitability, with a 84.78% decrease in profit. The company's net worth Soared by an impressive increase of 16.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trulay Pharmaceuticals?
In 2021, Trulay Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kavish Meditech LlpNisha Vithlani is a mutual person
-
Nolen Lifesciences Private Limited
Dharmeshbhai Vara is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trulay Pharmaceuticals?
Trulay Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trulay Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trulay Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
